Bottle of lies: ranbaxy and the dark side of indian pharma
Publication details: New Delhi Juggernaut Books 2019Description: xxiv, 482 HardboundISBN:- 978-93-5345-044-1
- 615.1/Eba/37087 11137087
| Item type | Current library | Call number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|
Book
|
Main Library | 615.1/Eba/37087 (Browse shelf(Opens below)) | Available | 11137087 |
Browsing Main Library shelves Close shelf browser (Hides shelf browser)
| No cover image available | No cover image available | No cover image available | ||||||
| 615.1 / DES / 14690 MCQS IN PHARMACOLOGY: | 615.1 / DHI / 14692 PHARMACOLOGY: | 615.1 / DHI / 14693 LAST MINUTE REVISION IN PHARMACOLOGY: | 615.1/Eba/37087 Bottle of lies: ranbaxy and the dark side of indian pharma | 615.1 / MAT / 668 NEW DRUG DEVELOPMENT:A REGULATORY OVERVIEW | 615.1 / PA / 1764 THE RX FACTOR:STRATEGIC CREATIVITY IN PHARMACEUTICAL MARKETING | 615.1 / S K / 586 INTRODUCTION TO PHARMACOLOGY: |
In 2004, Dinesh Thakur, an employee of Ranbaxy discovered a terrible secret. Ranbaxy had been fabricating the test results of their drugs, endangering millions of patients. This is the sensational account of the fall from grace of India’s largest pharma. But the rot in Indian pharma isn’t confined to Ranbaxy alone. In this book, investigative journalist Katherine Eban also raises troubling questions about some of its biggest names – Wockhardt, Dr Reddy’s, Glenmark and RPG Life Sciences. Filled with shocking and eye-opening details, It will make you view every pill you take with foreboding and suspicion.
There are no comments on this title.